www.fdanews.com/articles/189477-medtronic-agrees-to-51-million-payout-to-settle-three-claims
Medtronic Agrees to $51 Million Payout to Settle Three Claims
December 10, 2018
Medtronic agreed to make payments totaling $51 million to settle claims by the Department of Justice against Covidien and ev3, two firms it acquired in 2015.
The company will hand over $20 million to the DOJ to settle an investigation of market-development and physician engagement activities by Covidien and ev3 Peripheral Vascular and endoVenous businesses. Covidien acquired ev3 in 2010.
Ev3 agreed to plead guilty to misdemeanor charges that it encouraged unproven and potentially dangerous uses of its Onyx Liquid Embolic System.